N-terminal prohormone B-type natriuretic peptide and cardiovascular risk in stable coronary artery disease: A meta-analysis of nine prospective studies

Reviews in Cardiovascular Medicine

Volumn 14, Issue 2-4, 2013, Pages

  Wei, Gao ^a   Yaqi, Ren ^a   Ningfu, Wang ^a   Xuwei, Hou ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Meta analysis; NT proBNP; Prognosis; Stable coronary artery disease

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; C REACTIVE PROTEIN; N TERMINAL PROHORMONE B TYPE NATRIURETIC PEPTIDE; UNCLASSIFIED DRUG;

ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CORONARY ARTERY DISEASE; DISEASE ASSOCIATION; HUMAN; META ANALYSIS; PROGNOSIS;

BIOLOGICAL MARKERS; CHI-SQUARE DISTRIBUTION; CORONARY ARTERY DISEASE; HUMANS; NATRIURETIC PEPTIDE, BRAIN; ODDS RATIO; PEPTIDE FRAGMENTS; PROGNOSIS; PROSPECTIVE STUDIES; RISK FACTORS; TIME FACTORS;

EID: 84893035012     PISSN: 15306550     EISSN: None     Source Type: Journal    
DOI: 10.3909/ricm0644     Document Type: Article

References (27)

1. Dickstein K, Cohen-Solal A, Filippatos G, et al ESC Committee for Practice Guidelines (CPG). ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur Heart J. 2008;29:2388-2442.
2. Goetze JP, Christoffersen C, Perko M, et al. Increased cardiac BNP expression associated with myocardial ischemia. FASEB J. 2003;17:1105-1107.
3. Di Angelantonio E, Chowdhury R, Sarwar N, et al. B-type natriuretic peptides and cardiovascular risk: systematic review and meta-analysis of 40 prospective studies. Circulation. 2009;120:2177-2187.
4. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327:557-560. (Pubitemid 37088507)
5. Mayer O Jr, Simon J, Plásková M, et al. N-terminal pro B-type natriuretic peptide as prognostic marker for mortality in coronary patients without clinically manifest heart failure. Eur J Epidemiol. 2009;24:363-368.
6. Richards M, Nicholls MG, Espiner EA, et al. Comparison of B-type natriuretic peptides for assessment of cardiac function and prognosis in stable ischemic heart disease. J Am Coll Cardiol. 2006;47:52-60. (Pubitemid 43005164)
7. Dai DF, Hwang JJ, Lin JL, et al. Joint effects of N-terminal pro-B-type-natriuretic peptide and Creactive protein vs angiographic severity in predicting major adverse cardiovascular events and clinical restenosis after coronary angioplasty in patients with stable coronary artery disease. Circ J . 2008;72:1316-1323.
8. Ndrepepa G, Kastrati A, Braun S, et al. N-terminal probrain natriuretic peptide and C-reactive protein in stable coronary heart disease. Am J Med. 2006;119:355.e1-e8.
9. Harutyunyan MJ, Mathiasen AB, Winkel P, et al CLARICOR Trial Group. High-sensitivity C-reactive protein and N-terminal pro-B-type natriuretic peptide in patients with stable coronary artery disease: a prognostic study within the CLARICOR trial. Scand J Clin Lab Invest. 2011;71:52-62.
10. Ndrepepa G, Braun S, Mehilli J, et al. Accuracy of N-terminal probrain natriuretic peptide to predict mortality or detect acute ischemia in patients with coronary artery disease. Cardiology. 2008;109:249-257. (Pubitemid 351328920)
11. Omland T, Sabatine MS, Jablonski KA, et al PEACE Investigators. Prognostic value of B-Type natriuretic peptides in patients with stable coronary artery disease: the PEACE Trial. J Am Coll Cardiol. 2007;50:205-214. (Pubitemid 47031568)
12. März W, Tiran B, Seelhorst U, et al LURIC Study Team. N-terminal pro-B-type natriuretic peptide predicts total and cardiovascular mortality in individuals with or without stable coronary artery disease: the Ludwigshafen Risk and Cardiovascular Health Study. Clin Chem. 2007;53:1075-1083. (Pubitemid 46867524)
13. Bibbins-Domingo K, Gupta R, Na B, et al. N-terminal fragment of the prohormone brain-type natriuretic peptide (NT-proBNP), cardiovascular events, and mortality in patients with stable coronary heart disease. JAMA. 2007;297:169-176. (Pubitemid 46089733)
14. Rothenbacher D, Koenig W, Brenner H. Comparison of N-terminal pro-B-natriuretic peptide, C-reactive protein, and creatinine clearance for prognosis in patients with known coronary heart disease. Arch Intern Med. 2006;166:2455-2460. (Pubitemid 44913229)
15. Ndrepepa G, Braun S, Niemöller K, et al. Prognostic value of N-terminal pro-brain natriuretic peptide in patients with chronic stable angina. Circulation. 2005;112:2102-2107. (Pubitemid 41475802)
16. Kragelund C, Grønning B, Køber L, et al. N-terminal pro-B-type natriuretic peptide and long-term mortality in stable coronary heart disease. N Engl J Med. 2005;352:666-675. (Pubitemid 40239214)
17. Schnabel R, Rupprecht HJ, Lackner KJ, et al Athero-Gene Investigators. Analysis of N-terminal-pro-brain natriuretic peptide and C-reactive protein for risk stratification in stable and unstable coronary artery disease: results from the AtheroGene study. Eur Heart J. 2005;26:241-249. (Pubitemid 40222362)
18. Goetze JP, Christoffersen C, Perko M, et al. Increased cardiac BNP expression associated with myocardial ischemia. FASEB J. 2003;17:1105-1107.
19. Goetze JP, Gore A, Møller CH, et al. Acute myocardial hypoxia increases BNP gene expression. FASEB J. 2004;18:1928-1930. (Pubitemid 39602287)
20. Pascual-Figal DA, Antolinos MJ, Bayes-Genis A, et al. B-type natriuretic peptide release in the coronary effluent after acute transient ischaemia in humans. Heart. 2007;93:1077-1080. (Pubitemid 47310986)
21. Goetze JP, Yongzhong W, Rehfeld JF, et al. Coronary angiography transiently increases plasma pro-B-type natriuretic peptide. Eur Heart J. 2004;25:759-764. (Pubitemid 38647936)
22. Tateishi J, Masutani M, Ohyanagi M, Iwasaki T. Transient increase in plasma brain (B-type) natriuretic peptide after percutaneous transluminal coronary angioplasty. Clin Cardiol. 2000;23:776-780.
23. Rana BS, Davies JI, Band MM, et al. B-type natriuretic peptide can detect silent myocardial ischaemia in asymptomatic type 2 diabetes. Heart. 2006;92:916-920. (Pubitemid 43974053)
24. Sadanandan S, Cannon CP, Chekuri K, et al. Association of elevated B-type natriuretic peptide levels with angiographic findings among patients with unstable angina and non-ST-segment elevation myocardial infarction. J Am Coll Cardiol. 2004;44:564-568. (Pubitemid 39078180)
25. Partanen N, Husso M, Vuolteenaho O, et al. N-terminal pro-atrial natriuretic peptide reflects cardiac remodelling in stage 1 hypertension. J Hum Hypertens. 2011;25:746-751.
26. Marsiliani D, Buccelletti F, Carroccia A, et al. Natriuretic peptides and atrial fibrillation. Eur Rev Med Pharmacol Sci. 2010;14:855-860.
27. Khalifeh N, Haider D, Hörl WH. Natriuretic peptides in chronic kidney disease and during renal replacement therapy: an update. J Investig Med. 2009;57:33-39.